A call for rational intensive care in the era of COVID-19

American Journal of Respiratory Cell and Molecular Biology

Volumn 63, Issue 1, 2020, Pages 132-133

  Singer, Benjamin D ^a   Jain, Manu ^a   Budinger, G R Scott ^a   Wunderink, Richard G ^a  

^a NORTHWESTERN UNIVERSITY   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ASCORBIC ACID; AZITHROMYCIN; BETA INTERFERON; CONVALESCENT PLASMA; DOXYCYCLINE; ECULIZUMAB; GAMMA INTERFERON; GLUCOCORTICOID; HYDROXYCHLOROQUINE; INTERLEUKIN 1 RECEPTOR BLOCKING AGENT; LOPINAVIR PLUS RITONAVIR; LOW MOLECULAR WEIGHT HEPARIN; NITRIC OXIDE; REMDESIVIR; TISSUE PLASMINOGEN ACTIVATOR; TOCILIZUMAB; CYTOKINE;

ADULT RESPIRATORY DISTRESS SYNDROME; ARTIFICIAL VENTILATION; CORONAVIRUS DISEASE 2019; EMOTION; HEALTH CARE QUALITY; HUMAN; HYPOXEMIA; INTENSIVE CARE; INTENSIVIST; LETTER; LUNG COMPLIANCE; LUNG EDEMA; MESENCHYMAL STEM CELL; MULTIPLE ORGAN FAILURE; PANDEMIC; RESPIRATORY SYSTEM; TREATMENT OUTCOME; VIRUS PNEUMONIA; BETACORONAVIRUS; CORONAVIRUS INFECTION; METABOLISM; PHYSICIAN ATTITUDE; VIROLOGY;

BETACORONAVIRUS; CORONAVIRUS INFECTIONS; CRITICAL CARE; CYTOKINES; HUMANS; PANDEMICS; PHYSICIAN'S ROLE; PNEUMONIA, VIRAL;

EID: 85084616623     PISSN: 10441549     EISSN: 15354989     Source Type: Journal    
DOI: 10.1165/rcmb.2020-0151LE     Document Type: Letter

References (7)

1. Bellani G, Laffey JG, Pham T, Fan E, Brochard L, Esteban A, et al.; LUNG SAFE Investigators; ESICM Trials Group. Epidemiology, patterns of care, and mortality for patients with acute respiratory distress syndrome in intensive care units in 50 countries. JAMA 2016;315: 788-800.
2. Ranieri VM, Rubenfeld GD, Thompson BT, Ferguson ND, Caldwell E, Fan E, et al.; ARDS Definition Task Force. Acute respiratory distress syndrome: the Berlin Definition. JAMA 2012;307:2526-2533.
3. Gattinoni L, Chiumello D, Caironi P, Busana M, Romitti F, Brazzi L, et al. COVID-19 pneumonia: different respiratory treatments for different phenotypes? Intensive Care Med [online ahead of print] 14 Apr 2020; DOI: 10.1007/s00134-020-06033-2.
4. Brower RG, Matthay MA, Morris A, Schoenfeld D, Thompson BT, Wheeler A; Acute Respiratory Distress Syndrome Network. Ventilation with lower tidal volumes as compared with traditional tidal volumes for acute lung injury and the acute respiratory distress syndrome. N Engl J Med 2000;342:1301-1308.
5. Guérin C, Reignier J, Richard JC, Beuret P, Gacouin A, Boulain T, et al.; PROSEVA Study Group. Prone positioning in severe acute respiratory distress syndrome. N Engl J Med 2013;368: 2159-2168.
6. Lewis SR, Pritchard MW, Thomas CM, Smith AF. Pharmacological agents for adults with acute respiratory distress syndrome. Cochrane Database Syst Rev 2019;7:CD004477.
7. Cao B, Wang Y, Wen D, Liu W, Wang J, Fan G, et al. A trial of lopinavir-ritonavir in adults hospitalized with severe Covid-19. N Engl J Med [online ahead of print] 18 Mar 2020; DOI: 10.1056/ NEJMoa2001282.